Breaking alert: rosen, a longstanding and trusted firm, encourages sonoma pharmaceuticals, inc. investors with losses to inquire about securities class action investigation – snoa

New york, feb. 15, 2021 (globe newswire) -- why: rosen law firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of sonoma pharmaceuticals, inc. (nasdaq: snoa) resulting from allegations that sonoma may have issued materially misleading business information to the investing public.
SNOA Ratings Summary
SNOA Quant Ranking